The Fight Against COVID19
23.59k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | -1.64% | - | - | - |
| ^GSPC | -1.61% | +5.24% | -12.75% | +4207.75% |
14 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 178.76 | -0.12 | -0.07% | 1:22 p.m. EST | 2.53M | 7.06M | 467.36B |
| ABBV | AbbVie Inc. | 164.12 | +0.46 | +0.28% | 1:22 p.m. EST | 2.52M | 5.65M | 290.24B |
| PFE | Pfizer Inc. | 50.535 | -0.38 | -0.74% | 1:22 p.m. EST | 7.92M | 20.14M | 283.67B |
| SNY | Sanofi | 45.11 | +0.10 | +0.22% | 1:22 p.m. EST | 893.88k | 2.80M | 115.79B |
| GILD | Gilead Sciences, Inc. | 88.19 | -0.84 | -0.94% | 1:22 p.m. EST | 2.90M | 8.45M | 110.61B |
| REGN | Regeneron Pharmaceuticals, Inc. | 754.27 | -12.12 | -1.58% | 1:22 p.m. EST | 188.29k | 807.67k | 82.14B |
| GSK | GSK plc | 35.185 | -0.16 | -0.47% | 1:22 p.m. EST | 3.34M | 6.10M | 71.56B |
| MRNA | Moderna, Inc. | 174.1307 | -8.22 | -4.51% | 1:22 p.m. EST | 1.95M | 4.78M | 66.90B |
| TAK | Takeda Pharmaceutical Company Limited | 14.63 | -0.19 | -1.28% | 1:21 p.m. EST | 2.11M | 3.06M | 45.49B |
| BNTX | BioNTech SE | 166.54 | -3.20 | -1.89% | 1:22 p.m. EST | 665.71k | 889.44k | 40.42B |
| VIR | Vir Biotechnology, Inc. | 26.87 | -0.74 | -2.68% | 1:20 p.m. EST | 178.21k | 1.02M | 3.58B |
| NVAX | Novavax, Inc. | 17.0225 | +0.50 | +3.04% | 1:22 p.m. EST | 4.60M | 5.04M | 1.34B |
| INO | Inovio Pharmaceuticals, Inc. | 1.875 | -0.11 | -5.30% | 1:22 p.m. EST | 2.07M | 5.87M | 467.79M |
- TheStreet.com
Will Pfizer Shares Break Out or Reverse to the Downside?
With the broad market averages rallying this month the improvement in the charts of PFE could be more short covering than new outright buying. In this updated daily bar chart of PFE, below, we can see that prices have rallied from early October. The On-Balance-Volume (OBV) line is in a parallel upward trend and the Moving Average Convergence Divergence (MACD) oscillator is bullish.
- MarketWatch
China begins to loosen COVID rules
China’s decision to soften COVID-19 restrictions in the face of widespread protests cheered markets while also raising worries about a surge in infections
- Motley Fool
Why Shares of Provention Bio Went Up 30.3% in November
Shares of Provention Bio (NASDAQ: PRVB) rose 30.3% in November, according to data from S&P Global Intelligence. The pharmaceutical company closed out October at $6.94 and opened November at $7. The move up can be directly tied to the approval of Provention therapy Tzield (teplizumab-mzwv) by the Food and Drug Administration (FDA) on Nov. 17.
